Benchling Support & Services

ProPharma is committed to ensuring clients achieve optimal results. As your Benchling partner, our team of R&D Technology experts will ensure you obtain the most value from your Benchling software investment.

Partner icon

Post-Vendor Selection

Post-Vendor Selection

Spinning cog icon

R&D Evolution

R&D Evolution

Clinical technology services icon

Maximize ROI

Maximize ROI

Service icon

Reduce Burden

Reduce Burden

Regulatory Sciences icon

Customizable Services, Optimized Results

Customizable Services, Optimized Results

Post-Vendor Selection

Evaluating research platform capabilities for specific life sciences use cases can be complex, and challenges often persist when the software is implemented due to a lack of time, personnel, and in-house expertise.

Our consultants are Benchling specialists, which means we can provide strategic guidance and continually support your Benchling ecosystem according to both your short-term and long-term goals. This can include creating training tailored for your specific use cases to support user adoption and providing insights into effective change management strategies to help communicate the value the new platform can provide to their daily work.

Group of healthcare workers reviewing clipboards and tablet devices together

R&D Evolution

As your R&D science advances, workflows and reporting processes will also change and mature. Whether your business grows organically or through mergers and acquisitions, these natural progressions require appropriate adjustments to your supporting technologies, including Benchling configurations.

ProPharma can provide consultation and other support services to ensure your Benchling platform is maximized to support existing and future workflows as well as extending the platform to new user groups.

Gloved worker working with medical devices

Maximize ROI

Advances in Benchling features are constantly occurring; however, these additions or enhancements may require new system configurations, processes, and/or training to ensure full utilization and return on investment.

As a Benchling partner, we can help assess, advise, and configure new Benchling software releases for your use cases. Our consultants have deep scientific domain knowledge and laboratory experience as well as business consulting expertise which help us ensure your configured platform is fit-for-purpose.

Business worker collaborating around a blackboard

Reduce Burden

Although it is sometimes overlooked, maintaining and upgrading a research platform on an ongoing basis can create a significant resource burden. R&D scientists have numerous priorities, and managing and supporting software should not be one of them. Our team of Benchling specialists can mitigate the time and resource constraints associated with managing your research platform by providing ongoing support services for all your Benchling needs.

Two technicians working together in a lab at a computer

Customizable Services, Optimized Results

ProPharma is committed to improving the health and safety of patients by delivering the highest quality solutions and services throughout the full product lifecycle, including solving the complex challenges associated with data and technology. Our R&D Technology consultants combine scientific knowledge with hands-on laboratory research and technology expertise.

Group of professional women talking in a lobby

End-to-End Benchling Solutions

We have extensive experience supporting Benchling end-to-end solutions for the following:

Clinical Research Solutions icon

Protein-based Therapy

  • Monoclonal antibodies
  • Bispecific antibodies
  • Fusion proteins
Regulatory CMC icon

Cell Therapy

  • CAR-T generation
  • CAR-NK generation
  • Macrophage modulation
Full Service Clinical Trials icon

Gene Therapy

  • CRISPR
  • Coding RNA
  • Non-coding RNA
Woman wearing lab coat and gloves looking into microscope

Trusted Benchling Partner

Our combination of scientific knowledge, hands-on laboratory research, and technology expertise allows us to truly understand your needs and help ensure data protection, integrity, and utility. This agile and scalable approach enables us to deliver customized services that optimize results.

Our managed Benchling services can include:

Innovation icon

Project scoping, requirements gathering, document generation, and overall system assessment

Project scoping, requirements gathering, document generation, and overall system assessment

Read Less
Case management icon

Ongoing data governance, maintenance, and support of test and production environments

Ongoing data governance, maintenance, and support of test and production environments

Read Less
Computer System Validation icon

Data model configuration changes and refreshes

Data model configuration changes and refreshes

Read Less
Calendar icon

Office hours for users to ask questions, receive support, and gain knowledge of the platform

Office hours for users to ask questions, receive support, and gain knowledge of the platform

Read Less
Promotional review icon

Generating client-tailored training materials, customized for your specific use cases, to help ensure your team is using the Benchling platform to its fullest potential

Generating client-tailored training materials, customized for your specific use cases, to help ensure your team is using the Benchling platform to its fullest potential

Read Less
Gradient Image

Custom Managed Benchling Services

Contact us today to learn more about our Benchling services or speak with one of our experts. 

Benchling Experts

  • Warren Vieira Bio Photo

    Warren Vieira

    Senior R&D Technology Manager

    View Bio

  • Jenny Dao Bio Photo

    Jenny Dao

    Solutions Consultant

    View Bio

Warren is a problem solver by nature, driven to empower others with knowledge, critical thinking ability, and the right tools to be successful. Leveraging a combination IT and scientific knowledge, he leads a team of solution consultants to help organizations manage, structure, and govern their data. Warren has more than 3 years of Benchling experience and is able to support a diversity of use cases using the various Benchling applications.
Jenny graduated from Stanford University with a degree in Human Biology. As a Solutions Consultant within the R&D Technology Team, Jenny partners with startups, SMBs, and enterprise organizations to empower utilization, centralization, and standardization of scientific data. She has more than 3 years of Benchling experience, and can provide end-to-end support for a diverse array of scientific use cases using the Benchling software.

News & Insights

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

July 28, 2025

Understanding PADER: A Key Pharmacovigilance Requirement for the U.S. Market

Learn about PADER, a crucial pharmacovigilance requirement for U.S. drug safety monitoring, and how it differs from PSUR in ensuring compliance and patient safety. Summarizing the main point of the...

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guide for Marketing Authorization Holders (MAHs)

July 25, 2025

Understanding the Roles of LPPV, QPPV, and the PSMF in Pharmacovigilance: A Guid...

Learn about the crucial roles of QPPV, LPPV, and PSMF in ensuring effective pharmacovigilance and regulatory compliance for Marketing Authorization Holders (MAHs).

FDA Publishes over 200 Complete Response Letters (CRLs)

July 24, 2025

FDA Publishes over 200 Complete Response Letters (CRLs)

FDA's new transparency with over 200 CRLs empowers sponsors to navigate regulatory challenges more effectively, accelerating drug approvals and enhancing patient access to treatments.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Successfully Executing a Tech Transfer in a Week - ProPharma

July 29, 2025

Successfully Executing a Tech Transfer in a Week

Discover how ProPharma supported a $3B pharmaceutical tech transfer that was executed in just 3 days, relocating five complex product lines. The plan included FDA alignment, pre-approved protocols,...

Case Study Obesity – Accelerated Timelines - ProPharma

July 29, 2025

Obesity – Accelerated Timelines

A mid-size biotech needed fast U.S. market entry for an obesity trial. ProPharma activated 20 sites in 30 days and enrolled 300+ patients—meeting goals despite an increased sample size. Strategic...

Whitepapers Key Compliance Challenges in U.S. Medical Information Services - ProPharma

July 29, 2025

Key Compliance Challenges in U.S. Medical Information Services

For Medical Information (MI) teams navigating today’s evolving regulatory landscape, compliance isn’t just a requirement — it’s a strategic imperative. From managing off-label inquiries to...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow